Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation
Authors:
- Xinyi JiangXJXinyi Jiang
- Kitki LawKLKitki Law
- Yanzuo ChenYCYanzuo Chen
- Jijin GuJGJijin Gu
- Wei ZhangWZWei Zhang
- Hongliang XinHXHongliang Xin
- Xianyi ShaXianyi Sha
- Xiaoling FangXFXiaoling Fang
- 1 August 2011
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 415 (1-2) , 252-258
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cancer Therapies Utilizing the Camptothecins: A Review of thein VivoLiteratureMolecular Pharmaceutics, 2010
- Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrinJournal of Controlled Release, 2009
- Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapseCancer, 2008
- Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinomaWorld Journal of Gastroenterology, 2008
- Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in ratsBiopharmaceutics & Drug Disposition, 2006
- Effect of Phospholipid Composition on Characterization of Liposomes Containing 9-NitrocamptothecinDrug Development and Industrial Pharmacy, 2006
- A novel non-toxic camptothecin formulation for cancer chemotherapyBiomaterials, 2005
- Thyroid antibodies and tumor necrosis factor-a in patients with benign thyroid nodules treated by percutaneous ethanol injectionsInt. Journal of Clinical Pharmacology and Therapeutics, 2005
- Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety EvaluationJournal of Pharmaceutical Sciences, 1997
- Clinical Pharmacokinetics of TopotecanClinical Pharmacokinetics, 1996